Key Company Information

 

Year of Establishment : 1976
Country of Incorporation : Bangladesh
Commercial Production : 1980
Status : Public Limited Company
Business Lines : Manufacturing and marketing of pharmaceutical Finished Formulation Products, Large Volume Parenterals and Active Pharmaceutical Ingredients (APIs)
Main Country of operation : Bangladesh
Corporate Headquarter & Registered Address : 17 Dhanmondi R/A, Road No. 2, Dhaka- 1205, Bangladesh
Phone : +880-2-58611891
Fax : +880-2-58613470
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
Operational Headquarters
: 19 Dhanmondi R/A, Road No. 7, Dhaka- 1205, Bangladesh
Phone : +880-2-58611001-7
Fax : +880-2-58614601
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.
Website : www.beximcopharma.com
Overseas Offices & Associates : Australia, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines, Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen
Authorized Capital (Taka) : 9,100 million
Paid-up Capital (Taka) : 4,055.6 million
Number of Shareholders : Around 68,000
Stock Exchange Listings : Dhaka and Chittagong Stock Exchanges of Bangladesh and AIM of London Stock Exchange
Number of Employees : 3,500
TIDM: (Tradable Instrument Display Mnemonic) : BXP
Date shares were admitted to trading :
Dhaka Stock Exchange : 3 July, 1985
Chittagong Stock Exchange : 11 June, 1995
AIM ( Alternative Investment Market) : 21 October, 2005
ISIN : US0885792061